All Press Releases
Pila Pharma AB publishes interim report (1 January – 31 March 2023)
Malmö, April 26, 2023 PILA PHARMA AB (publ) (FN STO: PILA) today publishes the Company´s interim report for the period January – March 2023 and it is now available on the Company´s homepage, https://pilapharma.com/investors/finansiell-information/, and as an attachment to this press release. SUMMARY OF INTERIM REPORT First quarter (1 January - 31 March 2023) Revenue was 796 kSEK (535) Operating loss…
Pila Pharma AB publicerar årsredovisning för 2022
Malmö, 26 april 2023 Pila Pharma AB (publ) meddelar att årsredovisningen nu finns tillgänglig på bolagets hemsida: https://pilapharma.com/investors/finansiell-information/ samt som bilaga till detta pressmeddelande. VD kommenterar: ”Året 2022 blev ett år som präglats av två större aktiviteter i Pila Pharma. För det första genomförde vi de inledande två stegen i vår tre-stegsplan som presenterades i vår IPO 2021 och lyckades framgångsrikt att…
Pila Pharma AB publishes annual report for 2022
Malmö, April 26, 2023 PILA PHARMA AB (publ) (FN STO: PILA) announces that the annual report now is available on the Company´s homepage, https://pilapharma.com/investors/finansiell-information/, and as an attachment to this press release. CEO comments: ”The year 2022 was a year marked by two major activities in Pila Pharma. First, we completed the initial two steps of our three-step plan presented in…